Effects of the 2019 guideline update on lipid-lowering therapy in patients with acute coronary syndromes.

ABSTRACT:

Background

The European Society of Cardiology regularly updates its clinical practice guidelines. However, it is not well established whether guideline changes have significant effects on actual clinical practice. Therefore, we retrospectively analyzed lipid-lowering therapy at discharge after acute coronary syndrome (ACS) in a 1-year period before and a 1-year period after publication of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, respectively.

Methods and results

In total, we included 691 patients who were discharged alive after AMI. A total of 354 patients were treated in the period before, and 337 after the guideline change. After the guideline change, the proportion of patients discharged on high-dose statin was higher (89.3% vs 80.5%; p = 0.001) a

SUBMITTER: Galli L 

PROVIDER: S-EPMC12823727 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature